Jade Biomedical

Company Deals

Suzhou Jade Biomedical Partners with Hopstem Biotechnology for Cell Therapy Advancements

Fineline Cube Jan 23, 2024

Suzhou Jade Biomedical Co., Ltd, a prominent player in the Chinese biotech industry, has entered...

Company Deals

Suzhou Jade Biomedical Secures USD 10 Million Series B Financing

Fineline Cube Sep 15, 2022

China-based Suzhou Jade Biomedical Co., Ltd reportedly raised USD 10 million in a Series B...

Policy / Regulatory

U.S. Tariffs on Pharmaceuticals and Their Impact on China’s Medical Industry

Company Drug

Sichuan Biokin Launches Phase III Trial for BL-B01D1 in Urothelial Carcinoma

Company Drug

AbbVie’s Rinvoq Approved in EU for Giant Cell Arteritis

Company Drug

Bristol-Myers Squibb’s Opdivo/Yervoy Combo Approved for MSI-H Colorectal Cancer